REMINDER: Our user survey closes on Friday, please submit your responses here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksForterra Regulatory News (FORT)

Share Price Information for Forterra (FORT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 172.20
Bid: 170.60
Ask: 171.00
Change: 3.40 (2.01%)
Spread: 0.40 (0.234%)
Open: 162.60
High: 172.20
Low: 162.60
Prev. Close: 168.80
FORT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Post close half year trading update

11 Jul 2023 07:00

RNS Number : 5661F
Forterra plc
11 July 2023
 

11 July 2023

 

FORTERRA PLC

 

Post close half year trading update

 

In advance of the publication of our half year results on 27 July 2023 Forterra plc (the 'Group'), a leading UK manufacturer of essential clay and concrete building products, provides this trading update for the six-month period ending 30 June 2023 (the 'period').

 

Key points

 

· Resilient H1 results broadly in line with our expectations, delivered against a backdrop of challenging trading conditions

· We expect to report H1 revenues of approximately £183m, adjusted EBITDA of approximately £30m and adjusted PBT of approximately £18m

· Progressive signs of market improvement seen through May and June, although this improvement has been less pronounced than previously anticipated

· Considering the increasingly uncertain macroeconomic outlook we now expect to deliver full year 2023 EBITDA with a more balanced H1 / H2 split, reflecting only a modest improvement in trading conditions in H2

 

H1 results

 

· Subject to review by our auditors, we expect to report revenues for the period of approximately £183m, a decrease of 18% relative to the prior year (2022: £222.8m)

· We expect to report a resilient H1 result broadly in line with management expectations, with adjusted EBITDA of approximately £30m (2022: £46.1m) and adjusted PBT of approximately £18m (2022: £37.3m)

· Whilst market conditions remain competitive, our selling prices have remained firm and our cost base stable

· As planned, we have rebuilt our inventory, with stock levels increasing by approximately £30m in the period, leaving us well placed to deliver the service levels our customers expect

· We have maintained a strong and flexible balance sheet and expect to report a period end net debt before leases of approximately £50m (2022 year end: £5.9m) which is below 1x adjusted EBITDA on a LTM basis

 

Management actions

 

· In response to the challenging market conditions, and with our brick production capacity increasing with the opening of the new Desford factory, as previously announced, we have mothballed our Howley Park brick factory and implemented other production reductions which will reduce our fixed costs by around £10m on an annualised basis

· In addition, we are consulting with affected individuals on a restructuring of our commercial and support functions, aligning them to anticipated demand, which we expect to save approximately £3m annually

· The demand for our products in H2 will influence our production decisions. Having replenished our inventories in H1 we expect to limit our inventory growth in H2 and will continue to take appropriate action to ensure our output is aligned to demand

· Our strategy remains to maximise the ramp up of production at the new Desford factory, such that we can benefit from the market leading efficiencies it will offer once fully commissioned

 

Market backdrop and outlook

 

· UK brick industry despatches, as published by the Department of Business and Trade, were 31% adverse to the prior year in the five months to May 2023, with the month of May showing signs of an improving trend which is further evidenced by our own despatches for June, albeit this improvement is less pronounced than previously anticipated

· Encouragingly, imports of bricks to the UK have fallen significantly, decreasing 44% relative to 2022 in the four months to April, although they still remain high as a proportion of overall demand

· Although customer inventory reduction has been more prolonged than anticipated, we still expect this to ease in H2

· Demand for our products for the rest of the year remains subject to significant uncertainty with rising interest rates widely expected to adversely impact the demand for new homes for the foreseeable future

· Contrary to the wider macroeconomic backdrop, our precast flooring business, which can be regarded as a leading indicator for future brick and block demand is performing strongly, with despatches presently only 20% below prior year levels with current order intake running ahead of this

· As set out at the start of the year, our expectations for 2023 were based upon an underlying fall in full year market demand of 20% relative to 2022, with a slow start to the year followed by a meaningful recovery strengthening into H2 

· However, we are now assuming only a modest improvement in trading conditions, and therefore expect to deliver full year EBITDA with a more balanced H1 / H2 split

· The impacts of greater borrowing, inventory build, and rising interest rates are also expected to drive an increase in our financing costs

· Notwithstanding a weaker market in the short-term, looking further ahead, the Board remains confident that the Group remains well positioned to benefit from attractive market fundamentals of a shortage of UK housing supply, a shortfall of domestic brick production capacity and cross-party political support for increasing housing supply

 

This announcement contains inside information for the purposes of article 7 of the Market Abuse Regulation (EU) No 596/2014.

 

ENQUIRIES

 

Forterra plc +44 1604 707 600

Neil Ash, Chief Executive Officer

Ben Guyatt, Chief Financial Officer

 

FTI Consulting +44 203 727 1340

Richard Mountain / Nick Hasell

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFZGMNRGRGFZM
Date   Source Headline
10th Dec 20197:00 amRNSBoard Changes
6th Dec 201910:46 amRNSDirector/PDMR Shareholding
4th Dec 201912:01 pmRNSEmployee Benefit Trust Share Purchase
3rd Dec 20197:00 amRNSDirector/PDMR Shareholding
5th Nov 201912:38 pmRNSEmployee Benefit Trust Share Purchase
24th Oct 20199:51 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSTrading update
7th Oct 20192:03 pmRNSHolding(s) in Company
4th Oct 20192:09 pmRNSGrant of Options under 2018 SAYE Scheme
2nd Oct 20193:15 pmRNSEmployee Benefit Trust Share Purchase
26th Sep 20194:50 pmRNSEmployee Benefit Trust Share Purchase
9th Sep 20195:34 pmRNSDirector/PDMR Shareholding
4th Sep 20198:51 amRNSHolding(s) in Company
30th Jul 20197:00 amRNS2019 HALF YEAR RESULTS
4th Jul 201911:49 amRNSEmployee Benefit Trust Share Purchase
5th Jun 20199:20 amRNSEmployee Benefit Trust Share Purchase
20th May 20191:57 pmRNSResult of AGM
20th May 20197:00 amRNSAGM Trading Update
10th May 20193:08 pmRNSDirector/PDMR Shareholding
3rd May 20199:00 amRNSEmployee Benefit Trust Share Purchase
5th Apr 20192:50 pmRNSDirector/PDMR Shareholding
5th Apr 20192:49 pmRNSEmployee Benefit Trust Share Purchase
5th Apr 20191:21 pmRNSAnnual Report & Accounts 2018 and Notice of AGM
2nd Apr 20193:58 pmRNSDirector/PDMR Shareholding
29th Mar 20199:11 amRNSGrant under Performance Share Plan
29th Mar 20199:10 amRNSGrant under Deferred Annual Bonus Plan
14th Mar 201911:28 amRNSEmployee Benefit Trust Share Purchase
12th Mar 201910:00 amRNSEmployee Benefit Trust Share Purchase
5th Mar 20198:45 amRNSEmployee Benefit Trust Share Purchase
8th Feb 20199:00 amRNSDirector Declaration
8th Feb 20197:00 amRNSAppointment of new Independent NED
6th Feb 20191:30 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20191:38 pmRNSEmployee Benefit Trust Share Purchase
15th Jan 20197:00 amRNSTrading Update
8th Jan 20199:27 amRNSEmployee Benefit Trust Share Purchase
19th Dec 201810:09 amRNSEmployee Benefit Trust Share Purchase
4th Dec 20182:27 pmRNSEmployee Benefit Trust Share Purchase
27th Nov 201812:23 pmRNSHolding(s) in Company
20th Nov 201810:30 amRNSReplacement Director/PDMR Shareholding
20th Nov 20189:12 amRNSDirector/PDMR Shareholding
19th Nov 20181:30 pmRNSDirector/PDMR Shareholding
6th Nov 20188:55 amRNSEmployee Benefit Trust Share Purchase
1st Nov 20187:00 amRNSTrading Update
17th Oct 20188:49 amRNSHolding(s) in Company
16th Oct 20182:51 pmRNSHolding(s) in Company
9th Oct 20189:34 amRNSDirector Declaration
5th Oct 20182:07 pmRNSEmployee Benefit Trust Share Purchase
4th Oct 20188:58 amRNSGrant of Options under 2018 SAYE Scheme
27th Sep 20181:37 pmRNSHolding(s) in Company
18th Sep 20184:29 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.